Apoptosis of human intestinal epithelial cells after bacterial invasion.
Epithelial cells that line the human intestinal mucosa are the initial site of host invasion by bacterial pathogens. The studies herein define apoptosis as a new category of intestinal epithelial cell response to bacterial infection. Human colon epithelial cells are shown to undergo apoptosis following infection with invasive enteric pathogens, such as Salmonella or enteroinvasive Escherichia coli. In contrast to the rapid onset of apoptosis seen after bacterial infection of mouse monocyte-macrophage cell lines, the commitment of human intestinal epithelial cell lines to undergo apoptosis is delayed for at least 6 h after bacterial infection, requires bacterial entry and replication, and the ensuing phenotypic expression of apoptosis is delayed for 12-18 h after bacterial entry. TNF-alpha and nitric oxide, which are produced as components of the intestinal epithelial cell proinflammatory program in the early period after bacterial invasion, play an important role in the later induction and regulation of the epithelial cell apoptotic program. Apoptosis in response to bacterial infection may function to delete infected and damaged epithelial cells and restore epithelial cell growth regulation and epithelial integrity that are altered during the course of enteric infection. The delay in onset of epithelial cell apoptosis after bacterial infection may be important both to the host and the invading pathogen since it provides sufficient time for epithelial cells to generate signals important for the activation of mucosal inflammation and concurrently allows invading bacteria time to adapt to the intracellular environment before invading deeper mucosal layers.
Kim
J M
JM
Laboratory of Mucosal Immunology, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0623, USA.
Eckmann
L
L
Savidge
T C
TC
Lowe
D C
DC
Witthöft
T
T
Kagnoff
M F
MF
D000906:Antibodies / Q000494:pharmacology; D017209:Apoptosis; D001424:Bacterial Infections / Q000473:pathology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002478:Cells, Cultured; D003106:Colon / Q000166:cytology / Q000382:microbiology; D004847:Epithelial Cells / Q000166:cytology / Q000382:microbiology; D004926:Escherichia coli / Q000472:pathogenicity; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology* / Q000382:microbiology*; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000502:physiology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D012475:Salmonella / Q000472:pathogenicity; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000502:physiology
D000906:Antibodies; D001426:Bacterial Proteins; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase